drugset / Trial / NCT05075811

Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease

NCT05075811 ↗

Phase 1/2 Terminated 20 enrolled Anthony Lembo Ossium Health, Inc. · collab
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to determine the safety and feasibility of using Ossium vertebral Bone Marrow Derived Mesenchymal Stem Cells (vBM-MSC) to treat people with an ileal pouch anal anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch.

Timeline

Start
2022-02-01
Primary completion
2024-11-15
Completion
2024-11-15

Outcome

Outcome not reported

Stopped: “PI left institution”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ossium vBM-MSC Cell therapy 1e+08 cells Other